Rhopressa: Phase III started

Aerie began the double-blind, Canadian Phase III Rocket 3 trial to compare once- and twice-daily 0.02% Rhopressa eye drops vs. twice-daily timolol for 12 months in about 240 patients with glaucoma or ...